×

Mapping cytosine modifications

  • US 9,267,117 B2
  • Filed: 03/14/2013
  • Issued: 02/23/2016
  • Est. Priority Date: 03/15/2012
  • Status: Active Grant
First Claim
Patent Images

1. A composition comprising a reducing agent capable of converting 5-formylcytosine or 5-carboxycytosine to 5-hydroxymethylcytosine;

  • T4 β

    -glucosyltransferase (BGT) and a UDP derivative selected from the group consisting of UDP-glucose and UDP-azidoglucose.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×